Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesLandmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring
Gilead, 07/22/09
Gilead Sciences, Inc. highlighted results from a study known as DART (Development of Anti–Retroviral Treatment in Africa), which evaluated the need for routine laboratory monitoring in adults taking antiretroviral therapy in Africa. The DART trial was an open–label, randomized study comparing clinical and laboratory monitoring to clinical monitoring alone for efficacy and toxicity.
Related Articles
Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09
Relevance Score: 70%
Bone health in HIV infection
British Medical Bulletin, 10/30/09
Relevance Score: 69%
Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09
Relevance Score: 69%
Human Immunodeficiency Virus in an Aging Population, a Complication of Success
Journal of the American Geriatrics Society, 10/02/09
Relevance Score: 69%
Implant orthopaedic surgery in HIV asymptomatic carriers: Management and early outcome
Injury, 10/06/09
Relevance Score: 68%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/08/09
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
Clinical Pharmacology & Therapeutics, 12/08/09
Amgen Presents Data From First Nplate Study in Children With Chronic ITP
Amgen, 12/08/09
Nplate Data From MDS Studies Presented at ASH
Amgen, 12/07/09
Sponsor
Article Search
Sponsor